Related content

L858R-positive lung adenocarcinoma with KRAS G12V, EGFR T790M and EGFR L858R mutations: A case report

By Xiang Xianhong   Yu Jianxing   Lai Yingrong   He Weiling   Li Shuhua   Wang Liantang   Ke Zunfu  

Oncology Letters, Vol. 10, Iss. 3, 2015-09 ,pp. : 1293-1296

Spandidos Publications

Access to resources Recommend Favorite

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

By Rahman Shakibur   Kondo Nobuyuki   Yoneda Kazue   Takuwa Teruhisa   Hashimoto Masaki   Orui Hayato   Okumura Yoshitomo   Tanaka Fumihiro   Kumamoto Kanako   Mostafa Mohammad   Chowdhury Golam   Haque Akramul   Hasegawa Seiki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975/gefinitib-resistant with epidermal growth factor receptor T790M mutation

By                

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2767-2774

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer

By Riedel Richard F   Febbo Phillip G  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 461-466

Future Medicine

Access to resources Recommend Favorite

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics

By Motoshima Kohei   Nakamura Yoichi   Sano Kazumi   Ikegami Yoji   Ikeda Takaya   Mizoguchi Kosuke   Takemoto Shinnosuke   Fukuda Minoru   Nagashima Seiji   Iida Tetsuya   Tsukamoto Kazuhiro   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1299-1304

Springer Publishing Company

Access to resources Recommend Favorite